While NAFLD is mostly associated with hyperlipidemia (29), defective synthesis and secretion of ApoB lipoproteins can also lead to hepatic steatosis, as observed in patients with FHBL1 (9, 30). The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.